Compare GLSI & ANGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLSI | ANGI |
|---|---|---|
| Founded | 2006 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.2M | 266.7M |
| IPO Year | 2020 | 2017 |
| Metric | GLSI | ANGI |
|---|---|---|
| Price | $27.61 | $5.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $50.00 | $17.00 |
| AVG Volume (30 Days) | 118.4K | ★ 1.5M |
| Earning Date | 05-19-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1242.86 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $736,386,000.00 |
| Revenue This Year | N/A | $3.25 |
| Revenue Next Year | N/A | $3.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 47.60 |
| 52 Week Low | $7.78 | $4.53 |
| 52 Week High | $34.10 | $19.42 |
| Indicator | GLSI | ANGI |
|---|---|---|
| Relative Strength Index (RSI) | 60.08 | 37.59 |
| Support Level | $21.21 | $4.53 |
| Resistance Level | $30.08 | $8.03 |
| Average True Range (ATR) | 1.77 | 0.57 |
| MACD | 0.52 | -0.14 |
| Stochastic Oscillator | 75.41 | 20.47 |
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.